Skip to content
The Nexus
BUSINESSJun 27 · 10:00 UTCFINANCIAL TIMES WORLD

QuidelOrtho looks to sell testing unit as PE circles healthcare companies

QuidelOrtho plans to sell its testing unit amid private equity interest in healthcare companies. The company's shares have declined by 90% since its rapid antigen tests were the first approved for Covid-19.

Nexus surfaces and summarizes. The full story lives at the source.

Mentioned
QuidelOrthoorganizationPrivate Equityorganizationhealthcare companiestopicrapid antigen teststopictesting unittopic
Spot something wrong with this article?Report a problem →
Forward this
Related Signal

Adjacent reporting